Allhoff Benedict, Neumann-Haefelin Christoph, Kasper Philipp
Department of Gastroenterology and Hepatology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.
Biomedicines. 2025 Sep 8;13(9):2193. doi: 10.3390/biomedicines13092193.
Acute-on-chronic liver failure (ACLF) is a distinct clinical syndrome characterized by an acute decompensation of chronic liver disease in association with extrahepatic organ failure(s) and a high short-term mortality. Despite its increasing clinical relevance, there is no internationally standardized definition of ACLF to date. This review provides a comprehensive overview of current ACLF definitions, underlying pathogenic mechanisms, frequent precipitating events, and current treatment strategies. While liver transplantation remains the only curative treatment option, its role in the setting of ACLF is controversially debated, and patient selection remains complex due to high perioperative risk. Thus, the review article describes the current role of liver transplantation in patients with ACLF and describes novel prognostic scoring systems (e.g., TAM core, SALT-M model) that may be helpful in selecting suitable transplant candidates. Further emerging treatment options for ACLF include extracorporeal liver support systems, therapeutic plasma exchange, and immune-modulating approaches targeting toll-like receptor signaling that offer promising adjunctive strategies, though clinical evidence remains limited. Given the high burden and complexity of ACLF, harmonized definitions and evidence-based therapeutic frameworks are urgently needed to improve patient care and optimize transplant prioritization.
慢加急性肝衰竭(ACLF)是一种独特的临床综合征,其特征为慢性肝病急性失代偿,并伴有肝外器官功能衰竭以及高短期死亡率。尽管其临床相关性日益增加,但迄今为止尚无ACLF的国际标准化定义。本综述全面概述了当前ACLF的定义、潜在致病机制、常见诱发事件及当前治疗策略。虽然肝移植仍然是唯一的治愈性治疗选择,但其在ACLF中的作用存在争议,且由于围手术期风险高,患者选择仍然复杂。因此,这篇综述文章描述了肝移植在ACLF患者中的当前作用,并介绍了可能有助于选择合适移植候选者的新型预后评分系统(如TAM核心、SALT-M模型)。ACLF的其他新兴治疗选择包括体外肝支持系统、治疗性血浆置换以及针对Toll样受体信号传导的免疫调节方法,这些方法提供了有前景的辅助策略,尽管临床证据仍然有限。鉴于ACLF的高负担和复杂性,迫切需要统一的定义和基于证据的治疗框架,以改善患者护理并优化移植优先级。